Mitsubishi Tanabe Pharma America, Inc.

Form 483

Jersey City, New Jersey, United StatesFEI 3003777563Issued December 04, 2013

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3003777563.

Observations1

Issue DateDecember 04, 2013

StatusNo Warning Letter

Related Inspections3

Establishment Details

Firm: Mitsubishi Tanabe Pharma America, Inc.
Location: Jersey City, New Jersey, United States
FEI Number: 3003777563
Product Type: Drugs
Issue Date: December 04, 2013
Country: United States

Inspection History, 2013 to 2025

NAI1

VAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Mitsubishi Tanabe Pharma America, Inc. FDA Form 483, Jersey City, New Jersey, December 4, 2013